6.2.1 Thyroid hormones
| Pack |
|---|
| 28 tablet |
| Pack |
|---|
| 28 tablet |
| Pack |
|---|
| 28 tablet |
| Pack |
|---|
| 28 tablet |
For use in patients with persistent symptoms associated with switching between different levothyroxine tablet formulations in accordance with MHRA guidance.
| Pack |
|---|
| 100 ml |
For use in patients with persistent symptoms associated with switching between different levothyroxine tablet formulations in accordance with MHRA guidance.
| Pack |
|---|
| 100 ml |
For use in patients with persistent symptoms associated with switching between different levothyroxine tablet formulations in accordance with MHRA guidance.
| Pack |
|---|
| 100 ml |
Shared Care Guidelines do not apply
| Pack |
|---|
| 5 ampoule |
| Pack |
|---|
| 28 tablet |
| Pack |
|---|
| 100 tablet |
- First Line Drugs
- Second Line Drugs
- Specialist Initiated or Recommended Drugs
- Specialist Initiated Drugs with Shared Care Guidelines
- Specialist Only Drugs
- Mixed Status